本页面由Tiger Trade Technology Pte. Ltd.提供服务

亘喜生物

10.25
0.0000
成交量:- -
成交额:6,573.27万
市值:9.91亿
市盈率:-10.79
高:10.25
开:10.25
低:10.25
收:10.25
52周最高:10.44
52周最低:1.40
股本:9,671.24万
流通股本:3,327.85万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9502
每股收益(LYR):-1.3016
净资产收益率:-31.57%
总资产收益率:-19.41%
市净率:4.15
市盈率(LYR):-7.87

数据加载中...

2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/07

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/18

招股说明书

F-1 - Registration statement for certain foreign private issuers